tiprankstipranks
pc:avanz

Avanzanite Bioscience

Avanzanite Bioscience is a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases. The company aims to solve Europe's rare-disease medicines access gap by integrating commercial excellence, scientific expertise, and deep functional capability across market access, pricing, and reimbursement.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$32M
Total Amount Raised$32M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$32M
Latest Funding Amount$32M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 18, 2025
Series A
$32.00M

Investors

Investor Name
Funding Round
Series A

Related News and Analysis